Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)

General Information of Drug (ID: DR2132)
Drug Name
UDP-galactose
Synonyms
GALACTOSE-URIDINE-5'-DIPHOSPHATE; UDP-D-galactopyranose; UDP-D-galactose; UDP-Gal; UDP-alpha-D-Galactose; UDP-alpha-D-galactopyranose; UDP-galactopyranose; UDP-galactose; UDPgalactose; Udp galactose; Udpgal; Uridine 5'-diphosphogalactose; Uridine diphosphategalactose; Uridine diphosphogalactose; Uridine pyrophosphogalactose; Uridinediphosphate galactose; Uridinediphosphogalactose; uridine diphosphate galactose; 2956-16-3; CHEBI:67119; CHEMBL439009; GDU; Uridine-5'-diphosphate-alpha-D-galactose
Indication Discovery agent Investigative [1]
Structure
3D MOL 2D MOL
Pharmaceutical Properties Molecular Weight 566.3 Topological Polar Surface Area 292
Heavy Atom Count 36 Rotatable Bond Count 9
Hydrogen Bond Donor Count 9 Hydrogen Bond Acceptor Count 17
Cross-matching ID
PubChem CID
18068
PubChem SID
585432 ; 820510 ; 822374 ; 828118 ; 841579 ; 7887809 ; 8010104 ; 8163516 ; 10322886 ; 11532691 ; 16017796 ; 26702315 ; 29285756 ; 47169957 ; 50080759 ; 57329955 ; 77612459 ; 85198044 ; 85198047 ; 85856214 ; 85856216 ; 90344356 ; 99455629 ; 103516228 ; 104344147 ; 126523149 ; 134228784 ; 134356834 ; 134356838 ; 134356849 ; 134356851 ; 134419202 ; 134982455 ; 135651585 ; 137255161 ; 152186850 ; 152255822 ; 160645661 ; 160963343 ; 164161931 ; 164161944 ; 164194277 ; 223730435 ; 223730438 ; 227723596 ; 252452260 ; 252452263 ; 252452268
ChEBI ID
CHEBI:67119
CAS Number
2956-16-3
TTD Drug ID
D0K7WW
Formula
C15H24N2O17P2
Canonical SMILES
C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O
InChI
1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8+,9-,10+,11-,12-,13-,14-/m1/s1
InChIKey
HSCJRCZFDFQWRP-ABVWGUQPSA-N
The Metabolic Roadmap of This Drug
The Full List of Drug Metabolites (DM) of This Drug
DM Name DM ID PubChem ID Reaction DM Level REF
Galactose DM003154
6036
Oxidation - Hydrolyzationn 1 [2]
Galactose-1-phosphate DM001735
123912
Oxidation - Hydrolyzationn 1 [3]
UDP-glc DM004097
8629
Unclear 1 [7]
Glucose-1-phosphate DM004098
65533
Unclear 2 [7]
UDP-galactose DM004096
18068
Unclear 2 [7]
Glucose-6-phosphate DM004099
5958
Unclear 3 [6]
UDP-glc DM004097
8629
Unclear 3 [7]
Fru-6-P DM004100
69507
Unclear 4 [6]
Fructose-6-phosphate(F6P) DM004100
440641
Unclear 4 [6]
Glucose-1-phosphate DM004098
65533
Unclear 4 [7]
Glucose-6-phosphate DM004099
5958
Unclear 5 [6]
Fru-6-P DM004100
69507
Unclear 6 [6]
Fructose-6-phosphate(F6P) DM004100
440641
Unclear 6 [6]
⏷ Show the Full List of 13  DM(s)
The Full List of Metabolic Reaction (MR) of This Drug
MR ID Reactant Product MR Type DME REF
MR012928 UDP-galactose Galactose-1-phosphate Oxidation - Hydrolyzationn ENPP6 [3]
MR012934 UDP-galactose Galactose Oxidation - Hydrolyzationn ALP [2]
MR012929 Galactose-1-phosphate UDP-galactose Unclear Unclear [7]
MR012930 UDP-galactose UDP-glc Unclear Unclear [7]
MR012931 UDP-glc Glucose-1-phosphate Unclear Unclear [7]
MR012932 Glucose-1-phosphate Glucose-6-phosphate Unclear PGM1 [6]
MR012933 Glucose-6-phosphate Fru-6-P Unclear PGI [6]
⏷ Show the Full List of 7 MR(s)
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug
DME Name DME Info Species Uniprot ID EC Number REF
Alkaline phosphatase (ALP) DME1774 Capnocytophaga gingivalis
A0A250FL93_9FLAO
3.1.3.1
[2]
Choline glycerophosphodiester phosphodiesterase (ENPP6) DME0530 Homo sapiens
ENPP6_HUMAN
3.1.4.3
[3]
Collagen galactosyltransferase (COLGALT2) DME0559 Homo sapiens
GT252_HUMAN
2.4.1.50
[4]
Histo-blood group ABO system transferase (NAGAT) DME0552 Homo sapiens
BGAT_HUMAN
2.4.1.40
[5]
Phosphoglucomutase 1 (PGM1) DME0146 Homo sapiens
PGM1_HUMAN
5.4.2.2
[6]
UDP-glucose 4-epimerase (GALE) DMEN208 Homo sapiens
GALE_HUMAN
5.1.3.2
[7]
UDP-glucose pyrophosphorylase (UGPase) DME0514 Homo sapiens
UGPA_HUMAN
2.7.7.9
[7]
Unclear metabolic mechanism (DME-unclear) (PGI) DMEN207 Bacteroides fragilis Not Available Not Available [6]
Xylosylprotein 4-beta-galactosyltransferase (XGalT-1) DME0551 Homo sapiens
B4GT7_HUMAN
2.4.1.133
[8]
⏷ Show the Full List of 9  DME(s)
Experimental Enzyme Kinetic Data of This Drug
DME Name DME Info Kinetic Data Uniprot ID REF
Histo-blood group ABO system transferase (NAGAT) DME0552 Km = 0.027 microM
BGAT_HUMAN
[9]
Xylosylprotein 4-beta-galactosyltransferase (XGalT-1) DME0551 Km = 0.22 microM
B4GT7_HUMAN
[8]
Collagen galactosyltransferase (COLGALT2) DME0559 Km = 0.01877 microM
GT252_HUMAN
[4]
References
1 The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY. Nucleic Acids Res. 2020 Jan 8;48(D1):D1006-D1021. (Ligand id: 1782).
2 Using a Personal Glucose Meter and Alkaline Phosphatase for Point-of-Care Quantification of Galactose-1-Phosphate Uridyltransferase in Clinical Galactosemia Diagnosis
3 UDP-galactose hydrolysis in brain and its effect on cerebroside synthesis
4 Core glycosylation of collagen is initiated by two beta(1-O)galactosyltransferases. Mol Cell Biol. 2009 Feb;29(4):943-52.
5 Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase. Transfusion. 2007 May;47(5):864-75.
6 Defects in Galactose Metabolism and Glycoconjugate Biosynthesis in a UDP-Glucose Pyrophosphorylase-Deficient Cell Line Are Reversed by Adding Galactose to the Growth Medium
7 UDP-galactose 4'-epimerase activities toward UDP-Gal and UDP-GalNAc play different roles in the development of Drosophila melanogaster
8 Probing the acceptor active site organization of the human recombinant beta1,4-galactosyltransferase 7 and design of xyloside-based inhibitors. J Biol Chem. 2015 Mar 20;290(12):7658-70.
9 A single point mutation reverses the donor specificity of human blood group B-synthesizing galactosyltransferase. J Biol Chem. 2003 Apr 4;278(14):12403-5.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.